PUMA BIOTECHNOLOGY INC PBYI
COM · Common Stock · CUSIP 74587V107 · ISIN US74587V1070
Pharmaceutical company
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersLos Angeles, CA
- Websitepumabiotechnology.com
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once ($29.0k this quarter). Holder counts are more reliable. Shares outstanding: 45.6m as of 2022-10-31, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $2.37. Options: 6 managers hold calls ($1.1m notional), 4 hold puts ($134.0k).
Biggest calls
| MILLENNIUM MANAGEMENT LLC | — | $518.0k218.6k shares |
| SIMPLEX TRADING, LLC | — | $299.0k126.3k shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | — | $129.0k54.3k shares |
| GROUP ONE TRADING LLC | — | $72.0k30.3k shares |
| CITADEL ADVISORS LLC | — | $51.0k21.7k shares |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | — | $00 shares |
Biggest puts
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | — | $90.0k38.1k shares |
| CITADEL ADVISORS LLC | — | $44.0k18.7k shares |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | — | $00 shares |
| SIMPLEX TRADING, LLC | — | $0300 shares |
Options at notional value: the value of the shares the contracts control, as filers report them, not what the options cost. Not included in the holders, shares or buying above.
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
AUERBACH ALAN H
13D · may seek influence
filed 2026-10-06
Stated purposeThe information set forth or incorporated in Item 3 above is incorporated herein by reference. From time to time, Mr. Auerbach may acquire beneficial ownership of additional shares of Common Stock or other securities of the Issuer by purchase, as compensation from the Issuer, or otherwise, including, but not limited to, awards of restricted Common Shares, options to purchase Common Shares, and restricted stock units for Common Shares, or dispose of some or all of the shares of Common Stock beneficially owned by Mr. Auerbach in the open market or in privately negotiated transactions (which may be with the Issuer or with third parties) on such terms and at such times as Mr. Auerbach may deem advisable. Mr. Auerbach is the President, Chief Executive Officer and a director of the Issuer. In … Full filing |
16.0% |
| ACORN BIOVENTURES, L.P. 13G · passive investor +1.3 pts · filed 2025-02-14 | 8.0% |
| BlackRock, Inc. 13G · institution filed 2025-04-17 | 5.6% |
Fell to 5% or below in the last year: VANGUARD GROUP INC (0.0%, 2026-03-27)
Insider purchases and sales in Q3 2022
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q4 2020 | 0 | — | 0 | — | — |
| Q1 2021 | 0 | — | 0 | — | — |
| Q2 2021 | 0 | — | 0 | — | — |
| Q3 2021 | 0 | — | 0 | — | — |
| Q4 2021 | 0 | — | 4 | $38.9k | — |
| Q1 2022 | 0 | — | 5 | $205.1k | — |
| Q2 2022 | 0 | — | 8 | $255.0k | — |
| Q3 2022 | 0 | — | 6 | $225.0k | — |
| Date | Insider | Trade | Value |
|---|---|---|---|
| 2022-09-02 | AUERBACH ALAN H President and CEO, director | Sold | $3.2k1.3k shares |
| 2022-09-02 | HUNT DOUGLAS M Officer | Sold | $1.1k433 shares |
| 2022-09-02 | NOUGUES MAXIMO F Chief Financial Officer | Sold | $425164 shares |
| 2022-08-09 | MILLER MICHAEL PATRICK Director | Sold | $88.8k25.0k shares |
| 2022-08-02 | AUERBACH ALAN H President and CEO, director | Sold | $3.6k1.2k shares |
| 2022-08-02 | HUNT DOUGLAS M Officer | Sold | $1.2k429 shares |
| 2022-08-02 | NOUGUES MAXIMO F Chief Financial Officer | Sold | $465161 shares |
| 2022-07-05 | AUERBACH ALAN H President and CEO, director | Sold | $68.7k26.1k shares |
| 2022-07-05 | NOUGUES MAXIMO F Chief Financial Officer | Sold | $24.5k9.3k shares |
| 2022-07-05 | Ludwig Jeffrey Jerome Chief Commercial Officer | Sold | $15.3k5.8k shares |
| 2022-07-05 | HUNT DOUGLAS M Officer | Sold | $9.9k3.8k shares |
| 2022-07-05 | Wong Alvin F Chief Scientific Officer | Sold | $7.7k2.9k shares |
Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).
Holders, Q3 2022
| Manager | Shares | Change |
|---|---|---|
| Camber Capital Management LP 0.34% of their portfolio | 4.2m $10.0m | — |
| VANGUARD GROUP INC 0.00% of their portfolio | 3.6m $8.6m | — |
| MILLENNIUM MANAGEMENT LLC 0.01% of their portfolio | 2.8m $6.6m | — |
| BlackRock Inc. 0.00% of their portfolio | 1.9m $4.4m | — |
| ACADIAN ASSET MANAGEMENT LLC 0.02% of their portfolio | 1.8m $4.4m | — |
| RENAISSANCE TECHNOLOGIES LLC 0.01% of their portfolio | 1.8m $4.3m | — |
| Athyrium Capital Management, LP 1.59% of their portfolio | 1.8m $4.2m | — |
| Eversept Partners, LP 0.42% of their portfolio | 1.5m $3.6m | — |
| ARMISTICE CAPITAL, LLC 0.06% of their portfolio | 1.0m $2.4m | — |
| GLOBEFLEX CAPITAL L P 0.23% of their portfolio | 570.8k $1.4m | — |
| Kynam Capital Management, LP 0.28% of their portfolio | 559.8k $1.3m | — |
| D. E. Shaw & Co., Inc. 0.00% of their portfolio | 538.5k $1.3m | — |
| AlphaCentric Advisors LLC 1.01% of their portfolio | 415.0k $984.0k | — |
| MORGAN STANLEY 0.00% of their portfolio | 391.5k $928.0k | — |
| RICE HALL JAMES & ASSOCIATES, LLC 0.05% of their portfolio | 387.5k $918.0k | — |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 374.7k $887.0k | — |
| FEDERATED HERMES, INC. 0.00% of their portfolio | 355.4k $842.0k | — |
| Brandywine Global Investment Management, LLC 0.01% of their portfolio | 318.6k $755.0k | — |
| SEI INVESTMENTS CO 0.00% of their portfolio | 285.3k $676.0k | — |
| CITADEL ADVISORS LLC 0.00% of their portfolio | 210.0k $497.0k | — |
| TWO SIGMA ADVISERS, LP 0.00% of their portfolio | 186.6k $442.0k | — |
| LSV ASSET MANAGEMENT 0.00% of their portfolio | 182.1k $432.0k | — |
| STATE STREET CORP 0.00% of their portfolio | 181.7k $431.0k | — |
| Assenagon Asset Management S.A. 0.00% of their portfolio | 166.1k $394.0k | — |
| Connor, Clark & Lunn Investment Management Ltd. 0.00% of their portfolio | 149.3k $354.0k | — |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.00% of their portfolio | 143.9k $341.0k | — |
| GSA CAPITAL PARTNERS LLP 0.04% of their portfolio | 140.3k $333.0k | — |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.01% of their portfolio | 126.1k $299.0k | — |
| Ergoteles LLC 0.01% of their portfolio | 122.6k $291.0k | — |
| GOLDMAN SACHS GROUP INC 0.00% of their portfolio | 119.5k $284.0k | — |
| Russell Investments Group, Ltd. 0.00% of their portfolio | 99.1k $234.0k | — |
| TWO SIGMA INVESTMENTS, LP 0.00% of their portfolio | 83.6k $198.0k | — |
| Prospera Financial Services Inc 0.01% of their portfolio | 82.2k $195.0k | — |
| NORTHERN TRUST CORP 0.00% of their portfolio | 69.0k $163.0k | — |
| FMR LLC 0.00% of their portfolio | 64.3k $152.0k | — |
| Ally Bridge Group (NY) LLC 0.10% of their portfolio | 64.3k $152.0k | — |
| MACQUARIE GROUP LTD 0.00% of their portfolio | 61.3k $145.0k | — |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 60.7k $143.0k | — |
| DIMENSIONAL FUND ADVISORS LP 0.00% of their portfolio | 57.3k $136.0k | — |
| BAILARD, INC. 0.01% of their portfolio | 53.5k $127.0k | — |
| Patriot Financial Group Insurance Agency, LLC 0.03% of their portfolio | 50.5k $120.0k | — |
| PRICE T ROWE ASSOCIATES INC /MD/ 0.00% of their portfolio | 45.4k $108.0k | — |
| Bank of New York Mellon Corp 0.00% of their portfolio | 30.0k $71.0k | — |
| Crestline Management, L.P. 0.01% of their portfolio | 28.2k $67.0k | — |
| XTX Topco Ltd 0.02% of their portfolio | 28.1k $66.0k | — |
| Qube Research & Technologies Ltd 0.00% of their portfolio | 26.5k $63.0k | — |
| Atria Wealth Solutions, Inc. 0.00% of their portfolio | 25.2k $59.7k | — |
| FRANKLIN RESOURCES INC 0.00% of their portfolio | 24.2k $57.0k | — |
| Cubist Systematic Strategies, LLC 0.00% of their portfolio | 24.1k $57.0k | — |
| Man Group plc 0.00% of their portfolio | 20.2k $48.0k | — |
| DIVERSIFIED TRUST CO 0.00% of their portfolio | 20.2k $48.0k | — |
| BNP PARIBAS FINANCIAL MARKETS 0.00% of their portfolio | 19.9k $47.2k | — |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 19.4k $46.0k | — |
| Focus Partners Advisor Solutions, LLC 0.00% of their portfolio | 19.2k $46.0k | — |
| HSBC HOLDINGS PLC 0.00% of their portfolio | 18.9k $45.0k | — |
| Walleye Capital LLC 0.00% of their portfolio | 18.3k $43.0k | — |
| OSAIC HOLDINGS, INC. 0.00% of their portfolio | 17.5k $42.0k | — |
| SIMPLEX TRADING, LLC 0.00% of their portfolio | 15.9k $37.0k | — |
| Cambridge Investment Research Advisors, Inc. 0.00% of their portfolio | 14.9k $35.0k | — |
| Balyasny Asset Management L.P. 0.00% of their portfolio | 13.9k $33.0k | — |
| LMR Partners LLP 0.00% of their portfolio | 11.5k $27.0k | — |
| Running Point Capital Advisors, LLC 0.02% of their portfolio | 10.0k $24.0k | — |
| Leonteq Securities AG 0.00% of their portfolio | 6.0k $14.2k | — |
| Quantbot Technologies LP 0.00% of their portfolio | 4.5k $10.0k | — |
| UBS Group AG 0.00% of their portfolio | 3.4k $8.0k | — |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 2.8k $7.0k | — |
| Lindbrook Capital, LLC 0.00% of their portfolio | 2.8k $7.0k | — |
| GHP Investment Advisors, Inc. 0.00% of their portfolio | 1.2k $3.0k | — |
| MONEY CONCEPTS CAPITAL CORP 0.00% of their portfolio | 1.0k $2.0k | — |
| Geneos Wealth Management Inc. 0.00% of their portfolio | 1.0k $2.0k | — |
| Aspire Private Capital, LLC 0.00% of their portfolio | 700 $2.0k | — |
| Crewe Advisors LLC 0.00% of their portfolio | 579 $1.0k | — |
| CITIGROUP INC 0.00% of their portfolio | 548 $1.0k | — |
| China Universal Asset Management Co., Ltd. 0.00% of their portfolio | 426 $1.0k | — |
| Rockefeller Capital Management L.P. 0.00% of their portfolio | 275 $0 | — |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 260 $1.0k | — |
| US BANCORP \DE\ 0.00% of their portfolio | 200 $0 | — |
| Cutler Group LLC / CA 0.00% of their portfolio | 200 $0 | — |
| Quent Capital, LLC 0.00% of their portfolio | 143 $0 | — |
| PNC Financial Services Group, Inc. 0.00% of their portfolio | 123 $0 | — |
| Daiwa Securities Group Inc. 0.00% of their portfolio | 87 $0 | — |
| Key Financial Inc 0.00% of their portfolio | 50 $0 | — |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | — |